Skip to main content
OpenTrials
Completed

NCT Number: NCT05703529

Group-based Positive Psychotherapy in Psychological Resilience of Only-Child-Lost People

A randomized controlled trial was conducted to evaluate the effectiveness of group-based positive psychotherapy on psychological resilience, depression, well-being, sleep quality, dehydroepiandrosterone in only-child-lost people. A total of 80 only-child-lost people who met the inclusion and exclusion criteria were expected to recruit. There were six weeks in the intervention, including positive introduction, positive reaction, gratitude, meaningful, three good things, and using personal strength. The measurements were conducted at the baseline, immediately after the intervention, 3-month after the intervention.

Completed

Looking for future studies?

Notify Me

Key information

Age range

49 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • having only one child or legally adopting;
  • No surviving children;
  • basic language expression and comprehension skills;
  • the score of Connor-Davidson Resilience Scale is lower than 82

Exclusion criteria

  • in the acute bereavement period (<6 months);
  • unable to participate in activities due to severe physical illness;
  • having diagnosis of sever mental illness;
  • receiving other psychological therapy.

Treatment and study plan

Positive Psychotherapy

Behavioral

A 6-week group-based positive psychotherapy was conducted in this group. The themes of each week include positive introduction, three good things and positive reactions, gratitude, positive memory, identifying personal strengths and utilizing strengths.

Usual Care

Other

Usual Care means treating as usual, including a regular home visit.

Primary outcomes

  1. Change of psychological resilience

    Time frame: Baseline, immediately after the intervention, 3-month after the intervention

    It is assessed by Connor-Davidson Resilience Scale. A higher score suggests a higher level of psychological resilience. The range is 0-100.

Secondary outcomes

  1. Change of depressive symptoms

    Time frame: Baseline, immediately after the intervention, 3-month after the intervention

    It is measured by Zung Self-rating Depression Scale with a higher score suggesting a more severe of depressive symptoms

  2. Change of index of well-being

    Time frame: Baseline, immediately after the intervention, 3-month after the intervention

    It is measured by Campbell's Index of Well-being. A high score indicates a high level of well-being.

  3. Change of Dehydroepiandrosterone (DHEA) in saliva

    Time frame: Baseline, immediately after the intervention, 3-month after the intervention

    Saliva is collected using a saliva collector and assayed using the Elisa assay. After the specimens were collected, they were tested with the Elisa kit of Salimetrics® according to its instructions.

  4. Change of Sleep Quality

    Time frame: Baseline, immediately after the intervention, 3-month after the intervention

    It is measured by Pittsburgh Sleep Quality Index. If the total score is over 7, the sleep quality is normal, and if the score is over 7, it suggests a low sleep quality

  5. Change of Social Avoidance and Social Distress

    Time frame: Baseline, immediately after the intervention, 3-month after the intervention

    It is measured by Social Avoidance and Distress Scale. A high score indicates a high level of social avoidance and social distress.

Sponsors and collaborators

Lead sponsor

Central South University

Other

Registry information

Official study title

The Impact of Group-based Positive Psychotherapy in Psychological Resilience of Only-child-lost People: A Randomized Controlled Trial

Important dates

Study start
2016
Primary completion
2016
Study completion
2016
First posted
Jan 30, 2023
Registry last updated
Jan 30, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.